Literature DB >> 23018626

Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems.

Irina F Sevrioukova1, Thomas L Poulos.   

Abstract

Cytochromes P450 (CYPs) represent a diverse group of heme-thiolate proteins found in almost all organisms. CYPs share a common protein fold but differ in substrate selectivity and catalyze a wide variety of monooxygenation reactions via activation of molecular oxygen. Among 57 human P450s, the 3A4 isoform (CYP3A4) is the most abundant and the most important because it metabolizes the majority of administered drugs. A remarkable feature of CYP3A4 is its extreme promiscuity in substrate specificity and cooperative substrate binding, which often leads to undesirable drug-drug interactions and toxic side effects. Owing to its importance in drug development and therapy, CYP3A4 has been the most extensively studied mammalian P450. In this review we provide an overview on recent progress and remaining problems in the CYP3A4 research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23018626      PMCID: PMC3787833          DOI: 10.1039/c2dt31833d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  69 in total

1.  Possible pathway(s) of metyrapone egress from the active site of cytochrome P450 3A4: a molecular dynamics simulation.

Authors:  Weihua Li; Hong Liu; Xiaomin Luo; Weiliang Zhu; Yun Tang; James R Halpert; Hualiang Jiang
Journal:  Drug Metab Dispos       Date:  2007-01-24       Impact factor: 3.922

2.  Structure of microsomal cytochrome P450 2B4 complexed with the antifungal drug bifonazole: insight into P450 conformational plasticity and membrane interaction.

Authors:  Yonghong Zhao; Mark A White; B K Muralidhara; Ling Sun; James R Halpert; C David Stout
Journal:  J Biol Chem       Date:  2005-12-21       Impact factor: 5.157

3.  Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavir.

Authors:  D J Kempf; K C Marsh; G Kumar; A D Rodrigues; J F Denissen; E McDonald; M J Kukulka; A Hsu; G R Granneman; P A Baroldi; E Sun; D Pizzuti; J J Plattner; D W Norbeck; J M Leonard
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs.

Authors:  James McNulty; Jerald J Nair; Mohini Singh; Denis J Crankshaw; Alison C Holloway
Journal:  Bioorg Med Chem Lett       Date:  2010-02-04       Impact factor: 2.823

5.  Amino acid 305 determines catalytic center accessibility in CYP3A4.

Authors:  S M Fowler; R J Riley; M P Pritchard; M J Sutcliffe; T Friedberg; C R Wolf
Journal:  Biochemistry       Date:  2000-04-18       Impact factor: 3.162

6.  ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.

Authors:  D J Kempf; K C Marsh; J F Denissen; E McDonald; S Vasavanonda; C A Flentge; B E Green; L Fino; C H Park; X P Kong
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  How does the reductase help to regulate the catalytic cycle of cytochrome P450 3A4 using the conserved water channel?

Authors:  Dan Fishelovitch; Sason Shaik; Haim J Wolfson; Ruth Nussinov
Journal:  J Phys Chem B       Date:  2010-05-06       Impact factor: 2.991

8.  Homotropic cooperativity of monomeric cytochrome P450 3A4 in a nanoscale native bilayer environment.

Authors:  Bradley J Baas; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2004-10-15       Impact factor: 4.013

9.  Cytochrome P450 3A4 inhibition by ketoconazole: tackling the problem of ligand cooperativity using molecular dynamics simulations and free-energy calculations.

Authors:  Urban Bren; Chris Oostenbrink
Journal:  J Chem Inf Model       Date:  2012-06-04       Impact factor: 4.956

Review 10.  Cooperative properties of cytochromes P450.

Authors:  Ilia G Denisov; Daniel J Frank; Stephen G Sligar
Journal:  Pharmacol Ther       Date:  2009-06-23       Impact factor: 12.310

View more
  32 in total

1.  Pomegranate juice does not affect the disposition of simvastatin in healthy subjects.

Authors:  Soo-Jin Park; Chang-Woo Yeo; Eon-Jeong Shim; Hyunmi Kim; Kwang-Hyeon Liu; Jae-Gook Shin; Ji-Hong Shon
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-27       Impact factor: 2.441

Review 2.  Spectroscopic studies of the cytochrome P450 reaction mechanisms.

Authors:  Piotr J Mak; Ilia G Denisov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2017-06-28       Impact factor: 3.036

3.  De Novo Design, Solution Characterization, and Crystallographic Structure of an Abiological Mn-Porphyrin-Binding Protein Capable of Stabilizing a Mn(V) Species.

Authors:  Samuel I Mann; Animesh Nayak; George T Gassner; Michael J Therien; William F DeGrado
Journal:  J Am Chem Soc       Date:  2020-12-29       Impact factor: 15.419

Review 4.  Complexity of vitamin E metabolism.

Authors:  Lisa Schmölz; Marc Birringer; Stefan Lorkowski; Maria Wallert
Journal:  World J Biol Chem       Date:  2016-02-26

5.  7,8-benzoflavone binding to human cytochrome P450 3A4 reveals complex fluorescence quenching, suggesting binding at multiple protein sites.

Authors:  Glenn A Marsch; Benjamin T Carlson; F Peter Guengerich
Journal:  J Biomol Struct Dyn       Date:  2017-03-20

6.  Redox-dependent stability, protonation, and reactivity of cysteine-bound heme proteins.

Authors:  Fangfang Zhong; George P Lisi; Daniel P Collins; John H Dawson; Ekaterina V Pletneva
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-07       Impact factor: 11.205

7.  Identification of key licorice constituents which interact with cytochrome P450: evaluation by LC/MS/MS cocktail assay and metabolic profiling.

Authors:  Xue Qiao; Shuai Ji; Si-Wang Yu; Xiong-Hao Lin; Hong-Wei Jin; Yao-Kai Duan; Liang-Ren Zhang; De-An Guo; Min Ye
Journal:  AAPS J       Date:  2013-11-20       Impact factor: 4.009

8.  The McClure and Weiss models of Fe-O2 bonding for oxyhemes, and the HbO2 + NO reaction.

Authors:  Richard D Harcourt
Journal:  J Biol Inorg Chem       Date:  2013-12-07       Impact factor: 3.358

Review 9.  Ritonavir analogues as a probe for deciphering the cytochrome P450 3A4 inhibitory mechanism.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Curr Top Med Chem       Date:  2014       Impact factor: 3.295

10.  The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.

Authors:  Ilia G Denisov; Piotr J Mak; Yelena V Grinkova; Dominic Bastien; Gervais Bérubé; Stephen G Sligar; James R Kincaid
Journal:  J Inorg Biochem       Date:  2015-12-31       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.